<- Back to digest

JBJS - 2026-10-21 - Journal Article; Review

Changes in the Management of Periprosthetic Joint Infection Over the Past 50 Years.

Abedi AA, Pourbozorg G, Abdou M, Hoveidaei AH, Parvizi J, Citak M

systematic reviewLOE Vn = N/AN/A

Topics

arthroplasty
PMID: 42685157DOI: 10.2106/JBJS.26.00650View on PubMed ->

Key Takeaway

Over 50 years, PJI management has shifted from empiric clinical diagnosis to a multimodal framework using validated scoring systems (2018 ICM sensitivity 97.7%), synovial biomarkers, and individualized surgical strategies including DAIR, 1-stage, and 2-stage revision.

Summary Depth

Choose how much analysis to show on this article page.

Summary

This narrative review in JBJS synthesizes 50 years of evolution in PJI prevention, diagnosis, and surgical management. Diagnostic progress spans from culture-only reliance to multimodal frameworks integrating alpha-defensin (sensitivity 100%, specificity 96%), synovial WBC thresholds, and the 2018 ICM validated scoring system. Surgical strategy has moved from procedure-centered empiricism to host- and pathogen-tailored selection among DAIR, 1-stage revision, 2-stage revision, and salvage procedures, informed by biofilm biology and emerging microbiome science.

Key Limitation

As a narrative rather than systematic review, the absence of a reproducible search strategy and formal quality assessment of included studies limits the strength of conclusions drawn about comparative treatment efficacy.

Original Abstract

➢ Periprosthetic joint infection (PJI) remains a major complication of joint arthroplasty, associated with morbidity and health-care burden. Although room for progress remains, the management of PJI has evolved over the past 50 years from empiric, procedure-centered approaches to structured, evidence-based, and biologically informed strategies. ➢ This article summarizes key developments in the prevention, diagnosis, and treatment of PJI, driven by advances across multiple clinical and scientific subspecialties. ➢ Diagnostic approaches have advanced from reliance on clinical findings and culture to a multimodal framework integrating validated criteria, serological and synovial biomarkers, and molecular techniques. Surgical management has similarly evolved toward individualized strategies, including debridement with implant retention, 1-stage or 2-stage revision, and salvage surgery tailored to host, pathogen, and disease characteristics. ➢ Advances in microbiology, particularly the recognition of biofilm and the emerging role of the human microbiome, have further reshaped the understanding of PJI. Overall, this article examines how developments in prevention, diagnosis, surgical treatment, and microbiology have driven a transition toward precision-based, biology-informed, and individualized management of PJI.